Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Louis W. Sullivan currently holds 3,230 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis W. Sullivan has been a net seller of UTHR stock. They have purchased $43.9K and sold $39.3M worth of shares.
Louis W. Sullivan's most recent insider trade was on Dec 22, 2025, when they sold 3,230 shares at $183.98 per share.
Louis W. Sullivan serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 188 insider transactions totaling $39.4M over their tenure at the company.
Louis W. Sullivan holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Louis W. Sullivan has shown a selling trading pattern, with $43.9K in total purchases and $39.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Louis W. Sullivan was on May 11, 2021, when they sold $2.9M worth of UTHR shares. This transaction involved 15,000 shares at $194.30 per share.
Louis W. Sullivan currently owns 3,230 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Louis W. Sullivan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Louis W. Sullivan has 188 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for Louis W. Sullivan and 40,000+ other insiders.